These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 15766414

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W, Cui H, Chang XH, Cheng HY, Cheng YX, Feng J, Fu TY.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [Abstract] [Full Text] [Related]

  • 5. Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
    Scheibenbogen C, Sun Y, Keilholz U, Song M, Stevanovic S, Asemissen AM, Nagorsen D, Thiel E, Rammensee HG, Schadendorf D.
    Int J Cancer; 2002 Mar 20; 98(3):409-14. PubMed ID: 11920592
    [Abstract] [Full Text] [Related]

  • 6. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
    Liu W, Zhai M, Wu Z, Qi Y, Wu Y, Dai C, Sun M, Li L, Gao Y.
    Amino Acids; 2012 Jun 20; 42(6):2257-65. PubMed ID: 21710262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K.
    Int J Oncol; 2008 Sep 20; 33(3):433-41. PubMed ID: 18695871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine.
    Matsueda S, Shichijo S, Nagata S, Seki C, Yamada A, Noguchi M, Itoh K.
    Cancer Sci; 2015 Nov 20; 106(11):1493-8. PubMed ID: 26331453
    [Abstract] [Full Text] [Related]

  • 11. In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins.
    Asai T, Storkus WJ, Mueller-Berghaus J, Knapp W, DeLeo AB, Chikamatsu K, Whiteside TL.
    Cancer Immun; 2002 Apr 16; 2():3. PubMed ID: 12747748
    [Abstract] [Full Text] [Related]

  • 12. Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.
    Sotiropoulou PA, Perez SA, Voelter V, Echner H, Missitzis I, Tsavaris NB, Papamichail M, Baxevanis CN.
    Cancer Immunol Immunother; 2003 Dec 16; 52(12):771-9. PubMed ID: 13680193
    [Abstract] [Full Text] [Related]

  • 13. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Cancer; 2009 Feb 15; 115(4):800-11. PubMed ID: 19117353
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Forsberg O, Carlsson B, Malmström PU, Ullenhag G, Tötterman TH, Essand M.
    Prostate; 2009 Jan 01; 69(1):70-81. PubMed ID: 18814178
    [Abstract] [Full Text] [Related]

  • 16. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain.
    Okano F, Storkus WJ, Chambers WH, Pollack IF, Okada H.
    Clin Cancer Res; 2002 Sep 01; 8(9):2851-5. PubMed ID: 12231526
    [Abstract] [Full Text] [Related]

  • 17. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 18. Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia.
    Bai J, Wang J, Yang Y, Wang F, He A, Zhang W.
    J Immunother; 2021 May 01; 44(4):141-150. PubMed ID: 33596023
    [Abstract] [Full Text] [Related]

  • 19. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W.
    Cancer Res; 1998 Feb 15; 58(4):732-6. PubMed ID: 9485028
    [Abstract] [Full Text] [Related]

  • 20. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope].
    Zhu B, Chen ZT, Cheng XM, Wu YZ.
    Zhonghua Zhong Liu Za Zhi; 2004 Dec 15; 26(12):709-12. PubMed ID: 15733385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.